DF
DGX icon

Dunhill Financial’s Quest Diagnostics DGX Stock Holding History

Dunhill Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.3K Hold
218
– – 0.01% 345
2026
Q1 		$42.8K Sell
218
-45
-17% -$8.74K 0.01% 335
2025
Q4 		$45.6K Buy
263
+3
+1% +$546 0.01% 285
2025
Q3 		$49.5K Buy
260
+2
+0.8% +$355 0.01% 260
2025
Q2 		$46.5K Sell
258
-17
-6% -$2.95K 0.01% 248
2025
Q1 		$46.6K Sell
275
-2
-0.7% -$329 0.02% 198
2024
Q4 		$41.7K Sell
277
-113
-29% -$17.6K 0.02% 198
2024
Q3 		$60.6K Buy
390
+13
+3% +$1.94K 0.03% 154
2024
Q2 		$51.6K Buy
377
+125
+50% +$17.1K 0.03% 147
2024
Q1 		$33.6K Buy
252
+2
+0.8% +$259 0.02% 139
2023
Q4 		$34.4K Buy
+250
New +$32.9K 0.03% 122

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Dunhill Financial's DGX Position: Q2 2026 in Review

Dunhill Financial held its Quest Diagnostics (DGX) position steady in Q2 2026 at 218 shares worth $46.3K. The position accounts for 0.01% of the portfolio, ranked #345.

Dunhill Financial first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. The position peaked at $60.6K in Q3 2024. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Dunhill Financial held 218 shares of Quest Diagnostics worth $46.3K as of Q2 2026.
  • Dunhill Financial left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of Dunhill Financial's portfolio in Q2 2026, its #345 holding.
  • Dunhill Financial first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Quest Diagnostics position peaked at $60.6K in Q3 2024.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.